This page is part of the US Quality Core (v0.5.0: Release) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions
US Quality Core Not Done Recorded: 2017-01-17
status: Declined
statusReason: Drug treatment not indicated (situation)
medication: alcaftadine 2.5 MG/ML [Lastacaft]
authorizingPrescription: MedicationRequest: status = active; intent = order; medication[x] = ->Medication alemtuzumab 10 MG/ML [Lemtrada]; authoredOn = 2015-03-25 19:32:52-0500; reasonCode = Multiple sclerosis (disorder)
dosageInstruction
timing: 3 per 1 day
route: oral administration of treatment
DoseAndRates
Type Dose[x] Ordered 5 ml (Details: UCUM codeml = 'ml')